✦ LIBER ✦

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma

✍ Scribed by Ogura, Michinori; Tobinai, Kensei; Hatake, Kiyohiko; Uchida, Toshiki; Suzuki, Tatsuya; Kobayashi, Yukio; Mori, Masakazu; Terui, Yasuhito; Yokoyama, Masahiro; Hotta, Tomomitsu

Book ID: 119827185
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 230 KB
Volume: 104
Category: Article
ISSN: 1347-9032
DOI: 10.1111/cas.12040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Obinutuzumab (GA101) in Patients With Re

Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study

✍ Salles, G. A.; Morschhauser, F.; Solal-Celigny, P.; Thieblemont, C.; Lamy, T.; T 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 153 KB

Phase I and pharmacokinetic study of ben

Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Michinori Ogura; Toshiki Uchida; Masafumi Taniwaki; Kiyoshi Ando; Takashi Watana 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Multicenter phase II study of bendamusti

Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Ken Ohmachi; Kiyoshi Ando; Michinori Ogura; Toshiki Uchida; Kuniaki Itoh; Nobuko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Phase I study of the oral mammalian targ

Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma

✍ Kensei Tobinai; Michinori Ogura; Dai Maruyama; Toshiki Uchida; Naokuni Uike; Ils 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 345 KB

Japanese phase II study of 90Y-ibritumom

Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma

✍ Kensei Tobinai; Takashi Watanabe; Michinori Ogura; Yasuo Morishima; Tomomitsu Ho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

A phase II study of Xcellerated T cells™

A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)

✍ J.G. Gribben; N.L. Bartlett; J.J. Stephenson; M.S. Milder; R.V. Boccia; C. Redfe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB